The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis
Abstract The SEPT9 gene methylation assay is the first FDA-approved blood assay for colorectal cancer (CRC) screening. Fecal immunochemical test (FIT), FIT-DNA test and CEA assay are also in vitro diagnostic (IVD) tests used in CRC screening. This meta-analysis aims to review the SEPT9 assay perform...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/85bc8435fe9c4196991cda2e5dc58d96 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|